M.D., Ph.D., Associate Professor
Peking University Cancer Hospital
Dr. Xu received her medical degree in 1999 from Weifang Medical College, China. Since then, as a assistant professor she worked at department of immunology, Weifang Medical College. From 2002 to 2007, as a PhD. student, she studied at Peking University Cancer Hospital. Where she mainly focused on the predictive role of p53 gene in breast cancer. In 2007, she obtained her Ph.D. degree at Peking University. From then, she served as an assistant/associate professor at Peking University Cancer Hospital. In March 2015, as a visiting scientist, Dr Xu moved to Mayo Clinic, USA. Dr. Xu mainly focuses on the transnational research of breast cancer.
Her research interesting include (1) the prognostic or predictive markers that sort out the patients who may have a high risk of relapse, or discriminate the patients who may respond to a certain types of neoadjuvant chemotherapy regimens; (2) Germline mutations in BRCA1/2 or other susceptibility genes in Chinese women with early-onset or familial breast cancer.